1,2-dimethylhydrazine multiple interactions ISO Acsl5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ACSL5 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Acsl5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of ACSL5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ACSL5 mRNA CTD PMID:17108234 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ACSL5 mRNA CTD PMID:16174780 17beta-estradiol decreases expression ISO ACSL5 (Homo sapiens) 6480464 Estradiol results in decreased expression of ACSL5 mRNA CTD PMID:20106945 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ACSL5 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ACSL5 mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Acsl5 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ACSL5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ACSL5 mRNA CTD PMID:19692669 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ACSL5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28213091 and PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Acsl5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL5 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Acsl5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ACSL5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ACSL5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL5 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL5 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO ACSL5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of ACSL5 mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of ACSL5 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ACSL5 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression ISO ACSL5 (Homo sapiens) 6480464 3 more ... CTD PMID:19692669 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of ACSL5 mRNA CTD PMID:15953391 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ACSL5 mRNA CTD PMID:28522335 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of ACSL5 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO ACSL5 (Homo sapiens) 6480464 bisphenol S results in increased expression of ACSL5 mRNA CTD PMID:27685785 4-hydroxyphenyl retinamide increases expression ISO Acsl5 (Mus musculus) 6480464 Fenretinide results in increased expression of ACSL5 mRNA CTD PMID:28973697 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ACSL5 mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO ACSL5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of ACSL5 protein CTD PMID:20106945 antirheumatic drug decreases expression ISO ACSL5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of ACSL5 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO ACSL5 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ACSL5 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Acsl5 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACSL5 mRNA CTD PMID:23650126 arotinoid acid multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane multiple interactions ISO Acsl5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSL5 mRNA CTD PMID:32045263 arsenic atom multiple interactions ISO Acsl5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSL5 mRNA CTD PMID:32045263 ATP multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [ACSL5 protein affects the susceptibility to Palmitic Acid] which affects the abundance of Adenosine Triphosphate CTD PMID:32347412 azathioprine increases expression ISO ACSL5 (Homo sapiens) 6480464 Azathioprine results in increased expression of ACSL5 mRNA CTD PMID:22623647 belinostat decreases expression ISO ACSL5 (Homo sapiens) 6480464 belinostat results in decreased expression of ACSL5 mRNA CTD PMID:27188386 benzo[a]pyrene affects expression ISO ACSL5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the expression of ACSL5 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO ACSL5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ACSL5 5' UTR and Benzo(a)pyrene affects the methylation of ACSL5 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Acsl5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ACSL5 mRNA CTD PMID:19770486 and PMID:22228805 benzo[a]pyrene decreases expression ISO ACSL5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ACSL5 mRNA CTD PMID:22316170 and PMID:32234424 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ACSL5 mRNA CTD PMID:23292798 bezafibrate increases expression ISO Acsl5 (Mus musculus) 6480464 Bezafibrate results in increased expression of ACSL5 mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO Acsl5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of ACSL5 mRNA CTD PMID:30284816 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ACSL5 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO ACSL5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of ACSL5 protein CTD PMID:34186270 bisphenol A increases expression ISO Acsl5 (Mus musculus) 6480464 bisphenol A results in increased expression of ACSL5 mRNA CTD PMID:35479511 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACSL5 mRNA CTD PMID:32145629 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ACSL5 gene CTD PMID:28505145 bisphenol A multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects methylation ISO Acsl5 (Mus musculus) 6480464 bisphenol A affects the methylation of ACSL5 promoter CTD PMID:27334623 Bisphenol B increases expression ISO ACSL5 (Homo sapiens) 6480464 bisphenol B results in increased expression of ACSL5 protein CTD PMID:34186270 bisphenol F increases expression ISO ACSL5 (Homo sapiens) 6480464 bisphenol F results in increased expression of ACSL5 protein CTD PMID:34186270 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of ACSL5 mRNA CTD PMID:24136188 cadmium atom increases oxidation ISO Acsl5 (Mus musculus) 6480464 Cadmium results in increased oxidation of ACSL5 protein CTD PMID:24496640 carbon nanotube decreases expression ISO Acsl5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO ACSL5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ACSL5 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ACSL5 mRNA CTD PMID:18668222 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ACSL5 mRNA CTD PMID:22023808 clofibrate multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACSL5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACSL5 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ACSL5 mRNA CTD PMID:18670166 clofibrate increases expression ISO Acsl5 (Mus musculus) 6480464 Clofibrate results in increased expression of ACSL5 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO Acsl5 (Mus musculus) 6480464 cobaltous chloride results in decreased expression of ACSL5 mRNA CTD PMID:21139344 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ACSL5 mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of ACSL5 mRNA CTD PMID:20187946 copper(II) sulfate increases expression ISO ACSL5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ACSL5 mRNA CTD PMID:19549813 cortisol multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [4-(2-(5 more ... CTD PMID:34480604 cyclosporin A decreases expression ISO ACSL5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ACSL5 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO ACSL5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ACSL5 mRNA CTD PMID:25562108 and PMID:27989131 dexamethasone increases expression ISO ACSL5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of ACSL5 mRNA CTD PMID:25047013 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ACSL5 mRNA CTD PMID:17005392 and PMID:37077353 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL5 protein] CTD PMID:24146112 dioscin multiple interactions ISO Acsl5 (Mus musculus) 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL5 protein] CTD PMID:24146112 doxorubicin decreases expression ISO ACSL5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ACSL5 mRNA CTD PMID:29803840 ethanol decreases expression ISO Acsl5 (Mus musculus) 6480464 Ethanol results in decreased expression of ACSL5 protein CTD PMID:24146112 ethanol multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL5 protein] CTD PMID:24146112 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ACSL5 protein CTD PMID:24146112 ethanol multiple interactions ISO Acsl5 (Mus musculus) 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL5 protein] CTD PMID:24146112 farnesol multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [Farnesol analog co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA CTD PMID:30611723 fenofibrate increases expression ISO Acsl5 (Mus musculus) 6480464 Fenofibrate results in increased expression of ACSL5 mRNA CTD PMID:17118139 flutamide decreases expression ISO Acsl5 (Mus musculus) 6480464 Flutamide results in decreased expression of ACSL5 mRNA CTD PMID:17702527 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ACSL5 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Acsl5 (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of ACSL5 mRNA] CTD PMID:22206623 gamma-hexachlorocyclohexane decreases expression EXP 6480464 Hexachlorocyclohexane results in decreased expression of ACSL5 mRNA CTD PMID:17785943 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ACSL5 mRNA CTD PMID:22061828 and PMID:33387578 glyphosate decreases expression ISO Acsl5 (Mus musculus) 6480464 Glyphosate results in decreased expression of ACSL5 protein CTD PMID:37208198 GW 4064 increases expression ISO ACSL5 (Homo sapiens) 6480464 GW 4064 results in increased expression of ACSL5 mRNA CTD PMID:30611723 GW 7647 multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of ACSL5 mRNA CTD PMID:30611723 GW 7647 decreases expression EXP 6480464 GW 7647 results in decreased expression of ACSL5 mRNA CTD PMID:31628012 GW 7647 increases expression ISO ACSL5 (Homo sapiens) 6480464 GW 7647 results in increased expression of ACSL5 mRNA CTD PMID:30611723 and PMID:31628012 hexadecanoic acid multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [ACSL5 protein affects the susceptibility to Palmitic Acid] which affects the abundance of Adenosine Triphosphate CTD PMID:32347412 hexadecanoic acid increases expression ISO ACSL5 (Homo sapiens) 6480464 Palmitic Acid results in increased expression of ACSL5 mRNA CTD PMID:32347412 hexadecanoic acid affects response to substance ISO ACSL5 (Homo sapiens) 6480464 ACSL5 protein affects the susceptibility to Palmitic Acid CTD PMID:32347412 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of ACSL5 mRNA CTD PMID:36868495 isotretinoin decreases expression ISO ACSL5 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of ACSL5 mRNA CTD PMID:20436886 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of ACSL5 mRNA CTD PMID:37077353 L-ascorbic acid multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA CTD PMID:34480604 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of ACSL5 mRNA CTD PMID:24136188 lithium atom multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of ACSL5 mRNA] CTD PMID:19149911 lithium hydride multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of ACSL5 mRNA] CTD PMID:19149911 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ACSL5 mRNA CTD PMID:19149911 methamphetamine multiple interactions EXP 6480464 Lithium inhibits the reaction [Methamphetamine results in increased expression of ACSL5 mRNA] CTD PMID:19149911 methidathion affects expression ISO Acsl5 (Mus musculus) 6480464 methidathion affects the expression of ACSL5 mRNA CTD PMID:34813904 methylmercury chloride increases expression ISO ACSL5 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ACSL5 mRNA CTD PMID:28001369 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of ACSL5 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL5 mRNA CTD PMID:28943392 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of ACSL5 mRNA CTD PMID:24136188 nickel sulfate decreases expression ISO ACSL5 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of ACSL5 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ACSL5 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO ACSL5 (Homo sapiens) 6480464 methyleugenol results in decreased expression of ACSL5 mRNA CTD PMID:32234424 obeticholic acid increases expression ISO ACSL5 (Homo sapiens) 6480464 obeticholic acid results in increased expression of ACSL5 mRNA CTD PMID:27939613 oleic acid multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:30611723 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ACSL5 mRNA CTD PMID:23665939 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSL5 mRNA CTD PMID:25729387 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of ACSL5 mRNA CTD PMID:30316929 paracetamol multiple interactions ISO Acsl5 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACSL5 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACSL5 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ACSL5 mRNA CTD PMID:33387578 paracetamol decreases expression ISO ACSL5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ACSL5 mRNA CTD PMID:21420995 more ... paracetamol increases expression ISO ACSL5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ACSL5 mRNA CTD PMID:26690555 perfluorohexanesulfonic acid increases expression ISO Acsl5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of ACSL5 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid affects expression ISO Acsl5 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of ACSL5 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO Acsl5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of ACSL5 mRNA CTD PMID:20936131 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ACSL5 mRNA CTD PMID:18692542 perfluorooctanoic acid affects expression ISO Acsl5 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of ACSL5 mRNA CTD PMID:19429403 perfluorooctanoic acid multiple interactions ISO Acsl5 (Mus musculus) 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ACSL5 mRNA] CTD PMID:18467677 and PMID:20936131 perfluorooctanoic acid increases expression ISO Acsl5 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of ACSL5 mRNA CTD PMID:17681415 more ... perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ACSL5 mRNA CTD PMID:19162173 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of ACSL5 mRNA CTD PMID:15170462 pirinixic acid multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSL5 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Acsl5 (Mus musculus) 6480464 pirinixic acid results in increased expression of ACSL5 mRNA CTD PMID:15375163 more ... pirinixic acid multiple interactions ISO Acsl5 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACSL5 mRNA] CTD PMID:18467677 and PMID:20059764 potassium chromate decreases expression ISO ACSL5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ACSL5 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO Acsl5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of ACSL5 mRNA CTD PMID:28903501 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of ACSL5 mRNA CTD PMID:19423681 quercetin increases expression ISO ACSL5 (Homo sapiens) 6480464 Quercetin results in increased expression of ACSL5 mRNA CTD PMID:21632981 resveratrol increases expression ISO Acsl5 (Mus musculus) 6480464 resveratrol results in increased expression of ACSL5 mRNA CTD PMID:22610192 SB 431542 multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of ACSL5 mRNA CTD PMID:34480604 sodium arsenite multiple interactions ISO Acsl5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSL5 mRNA CTD PMID:32045263 sotorasib multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACSL5 mRNA CTD PMID:36139627 tetrachloroethene increases expression ISO Acsl5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of ACSL5 mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO Acsl5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ACSL5 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ACSL5 mRNA CTD PMID:31150632 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ACSL5 protein CTD PMID:35544339 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL5 mRNA CTD PMID:28943392 tolcapone decreases expression ISO ACSL5 (Homo sapiens) 6480464 tolcapone results in decreased expression of ACSL5 protein CTD PMID:29688484 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSL5 mRNA CTD PMID:25729387 trametinib multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACSL5 mRNA CTD PMID:36139627 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of ACSL5 mRNA CTD PMID:30589522 Triptolide decreases expression ISO Acsl5 (Mus musculus) 6480464 triptolide results in decreased expression of ACSL5 mRNA CTD PMID:32835833 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ACSL5 protein CTD PMID:21315101 tunicamycin increases expression ISO Acsl5 (Mus musculus) 6480464 Tunicamycin results in increased expression of ACSL5 mRNA CTD PMID:17127020 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of ACSL5 mRNA CTD PMID:24136188 valproic acid decreases expression ISO Acsl5 (Mus musculus) 6480464 Valproic Acid results in decreased expression of ACSL5 mRNA CTD PMID:21427059 valproic acid decreases expression ISO ACSL5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ACSL5 mRNA CTD PMID:29501571 valproic acid increases expression ISO ACSL5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ACSL5 mRNA CTD PMID:28001369 valproic acid increases expression ISO Acsl5 (Mus musculus) 6480464 Valproic Acid results in increased expression of ACSL5 mRNA CTD PMID:24489787 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ACSL5 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ACSL5 mRNA CTD PMID:22570695 XAV939 multiple interactions ISO ACSL5 (Homo sapiens) 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ACSL5 mRNA CTD PMID:34480604 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of ACSL5 mRNA CTD PMID:15671213 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of ACSL5 mRNA CTD PMID:15671213 zoledronic acid increases expression ISO ACSL5 (Homo sapiens) 6480464 zoledronic acid results in increased expression of ACSL5 mRNA CTD PMID:24714768